Initially dba Paravax, Inc., in 1995 the name was changed to Heska Corporation (NASDAQ:HSKA). To all intents, the firm ceased any form of SBIR involvement after that time conincident with the firm going pibllic in 1997. Focused to veterinary products for canine and feline companion animal health markets, operating in two segments: Core Companion Animal Health, and Other Vaccines Pharmaceuticals and Products. The former includes includes diagnostic and other instruments and supplies, as well as single use diagnostic and other tests, vaccines, and pharmaceuticals primarily for canine and feline use. This segment sells its products to veterinarians directly through its direct sales force and telephone sales force, as well as through independent third party distributors and other distribution relationships. The Other Vaccines, Pharmaceuticals and Products segment produces private label vaccines and pharmaceuticals primarily for cattle, as well as for other animals, including small mammals and fish. It offers bovine vaccines, and biological and pharmaceutical products; and turnkey services, which include research, licensing, production, labeling, and packaging of products
